enGene Therapeutics Inc. (ENGN) Net income 2022–2025
enGene Therapeutics Inc. (ENGN) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
-$117.3MFY2025 · since FY2022: -$24.5M → -$117.3M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$117.3M | -112.7% |
| FY2024 | -$55.1M | +44.8% |
| FY2023 | -$99.9M | -308.5% |
| FY2022 | -$24.5M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More ENGN financial trends
ENGN RevenueENGN Net marginENGN Gross profitENGN Gross marginENGN Operating incomeENGN Operating marginENGN Operating cash flowENGN Free cash flowENGN Capital expendituresENGN Return on equityENGN Stock buybacksENGN Dividends paidENGN Total assetsENGN Total liabilitiesENGN Shareholders’ equityENGN overview →